| Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients EN Baruch, I Youngster, G Ben-Betzalel, R Ortenberg, A Lahat, L Katz, ... Science 371 (6529), 602-609, 2021 | 990 | 2021 |
| Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response CN Spencer, JL McQuade, V Gopalakrishnan, JA McCulloch, M Vetizou, ... Science 374 (6575), 1632-1640, 2021 | 447 | 2021 |
| Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade MC Andrews, CPM Duong, V Gopalakrishnan, V Iebba, WS Chen, ... Nature medicine 27 (8), 1432-1441, 2021 | 269 | 2021 |
| Immune-related adverse events (irAEs): diagnosis, management, and clinical pearls EP Darnell, MJ Mooradian, EN Baruch, M Yilmaz, KL Reynolds Current oncology reports 22, 1-11, 2020 | 250 | 2020 |
| Proteomics of melanoma response to immunotherapy reveals mitochondrial dependence M Harel, R Ortenberg, SK Varanasi, KC Mangalhara, M Mardamshina, ... Cell 179 (1), 236-250. e18, 2019 | 238 | 2019 |
| Adoptive T cell therapy: an overview of obstacles and opportunities EN Baruch, AL Berg, MJ Besser, J Schachter, G Markel Cancer 123 (S11), 2154-2162, 2017 | 117 | 2017 |
| Prehospital administration of freeze-dried plasma, is it the solution for trauma casualties? A Shlaifer, M Siman-Tov, I Radomislensky, K Peleg, A Shina, EN Baruch, ... Journal of Trauma and Acute Care Surgery 83 (4), 675-682, 2017 | 77 | 2017 |
| ADAR1-mediated regulation of melanoma invasion Y Nemlich, EN Baruch, MJ Besser, E Shoshan, M Bar-Eli, L Anafi, ... Nature communications 9 (1), 2154, 2018 | 48 | 2018 |
| Possible immune adverse events as predictors of durable response to BRAF inhibitors in patients with BRAF V600–mutant metastatic melanoma G Ben-Betzalel, EN Baruch, B Boursi, Y Steinberg-Silman, N Asher, ... European Journal of Cancer 101, 229-235, 2018 | 46 | 2018 |
| Clinical significance of pancreatic atrophy induced by immune-checkpoint inhibitors: a case–control study Y Eshet, EN Baruch, R Shapira-Frommer, Y Steinberg-Silman, ... Cancer Immunology Research 6 (12), 1453-1458, 2018 | 39 | 2018 |
| Confidence–competence mismatch and reasons for failure of non-medical tourniquet users EN Baruch, JF Kragh Jr, AL Berg, JK Aden 3rd, A Benov, A Shina, ... Prehospital Emergency Care 21 (1), 39-45, 2017 | 38 | 2017 |
| Augmentation of point of injury care: reducing battlefield mortality—the IDF experience A Benov, E Glassberg, EN Baruch, S Avi, T Gilad, L Moran, Z Itay, S Ram, ... Injury 47 (5), 993-1000, 2016 | 36 | 2016 |
| Point of injury tourniquet application during Operation Protective Edge—What do we learn? A Shlaifer, A Yitzhak, EN Baruch, A Shina, A Satanovsky, A Shovali, ... Journal of Trauma and Acute Care Surgery 83 (2), 278-283, 2017 | 35 | 2017 |
| Gut microbiota and antitumor immunity: potential mechanisms for clinical effect EN Baruch, J Wang, JA Wargo Cancer Immunology Research 9 (4), 365-370, 2021 | 33 | 2021 |
| Recurrent pneumonitis in patients with melanoma treated with immune checkpoint inhibitors N Asher, EM Marom, G Ben‐Betzalel, EN Baruch, Y Steinberg‐Silman, ... The Oncologist 24 (5), 640-647, 2019 | 33 | 2019 |
| Does practice make perfect? Prospectively comparing effects of 2 amounts of practice on tourniquet use performance EN Baruch, A Benov, A Shina, AL Berg, A Shlaifer, E Glassberg, ... The American Journal of Emergency Medicine 34 (12), 2356-2361, 2016 | 27 | 2016 |
| Intravenous access in the prehospital settings: what can be learned from point-of-injury experience R Nadler, S Gendler, A Benov, A Shina, E Baruch, G Twig, E Glassberg Journal of Trauma and Acute Care Surgery 79 (2), 221-226, 2015 | 27 | 2015 |
| Physiologic colonic fluorine-18-fluorodeoxyglucose uptake may predict response to immunotherapy in patients with metastatic melanoma B Boursi, TJ Werner, S Gholami, O Margalit, E Baruch, G Markel, Y Eshet, ... Melanoma Research 29 (3), 318-321, 2019 | 21 | 2019 |
| TNFSF4 (OX40L) expression and survival in locally advanced and metastatic melanoma J Roszik, E Markovits, P Dobosz, A Layani, K Slabodnik-Kaner, ... Cancer Immunology, Immunotherapy 68, 1493-1500, 2019 | 20 | 2019 |
| Elective neck dissection versus observation in patients with head and neck cutaneous squamous cell carcinoma M Amit, C Liu, J Mansour, FO Gleber‐Netto, S Tam, EN Baruch, M Aashiq, ... Cancer 127 (23), 4413-4420, 2021 | 17 | 2021 |
